Sources | Names Used |
---|---|
CTRPv2 | BRD-K64610608 |
PharmacoGx | BRD-K64610608 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEX16 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | LDLRAD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | HSD17B3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | BCAT1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | CRACR2B | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | KRAS | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | PER2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | CRY2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
mRNA | ZNF408 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | DRC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |